ClinicalThought

Share

Program Content

Activities

  • Tazemetostat for R/R FL
    My Take on the Recent Approval of Tazemetostat for Relapsed/Refractory Follicular Lymphoma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 04, 2020

    Expires: August 03, 2021

  • Updated FL Tool
    An Updated Interactive Treatment Decision Support Tool for Follicular Lymphoma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 18, 2021

    Expires: March 17, 2022

Provided by

ProCE Banner

Supporters

Bayer Healthcare Pharma

Celgene

Epizyme, Inc.